The CD95 (APO-1/Fas) system plays a major role in induction of apoptosis in lymphoid and nonlymphoid tissues. The CD95 (APO-1/Fas) ligand (CD95L) is induced in response to a variety of signals including TCR/CD3 stimulation or application of chemotherapeutic drugs. Here we report that an AP-1 site located in the 5 0 untranslated region of the CD95L gene is required for TCR/CD3-mediated induction of the human CD95L promoter. Electrophoretic mobility shift assays using nuclear extracts of Jurkat T cells as well as TCR/CD3-restimulated primary human T cells demonstrated specific binding of AP-1, predominantly composed of c-Jun and FosB, to this sequence. Ectopic expression of transdominant negative Jun mutants strongly reduced CD95L promoter activity and activation-induced cell death (AICD), confirming the functional significance of FosB/ c-Jun binding. Thus, our results demonstrate an important novel function for FosB dimerized with c-Jun in TCR/ CD3-mediated AICD in human T cells. Oncogene (2003 Oncogene ( ) 22, 1333 Oncogene ( -1339 Oncogene ( . doi:10.1038 Keywords: activation-induced cell death; CD95 ligand; AP-1; T cells Death receptors, members of the TNFR/nerve growth factor receptor superfamily, play a central role in induction of apoptosis. Among them, CD95 (APO-1/ Fas) exerts a major function in induction of apoptosis in activated T cells upon TCR/CD3 restimulation, resulting in activation-induced cell death (AICD). This process represents the downphase of an immune response, which is necessary to maintain immune homeostasis and self-tolerance in the immune system (Dhein et al., 1995) . TCR/CD3 restimulation leads to the induction of CD95 ligand (CD95L) expression. Apoptosis is induced in CD95-bearing cells via the formation of a death-inducing signaling complex (DISC) and initiation of a signaling cascade of caspases finally leading to cell death . It has been shown previously that drug treatment can also induce apoptosis via the CD95/CD95L system (Friesen et al., 1996; Eichhorst et al., 2000) .
Upon TCR/CD3 stimulation, the binding of several transcription factors like NF-AT (Holtz-Heppelmann et al., 1998; Li-Weber et al., 1998 Norian et al., 1998; Kasibhatla et al., 1999) , Egr (early growth response protein) (Mittelstadt and Ashwell, 1998; Li-Weber et al., 1999; Mittelstadt and Ashwell, 1999) and IRF-1 (Chow et al., 2000) at the CD95L promoter in Jurkat T cells has been described. Several lines of evidence strongly suggest that, in addition to these factors, members of the Fos, Jun and ATF proteins, which form the transcription factor AP-1, are critically involved in CD95L expression and apoptosis. For example, upon TCR/CD3 stimulation, JNK/SAPKs become activated to hyperphosphorylate and thereby activate c-Jun (Su et al., 1994) . Furthermore, p38 MAPK and JNK were found to be involved in CD95L expression upon TCR/CD3 triggering in the murine system (Faris et al., 1998; Zhang et al., 2000) . In line with these data, MEKK and JNK/SAPK kinases mediating hyperphosphorylation, and thereby activation of the protooncogene c-Jun, participate in AP-1-dependent activation of CD95L gene expression upon genotoxic stress in murine and human cells Eichhorst et al., 2000; Kolbus et al., 2000; Chang and Karin, 2001) . While JunB and JunD have been linked to pro-and antiapoptotic activities, respectively (Passegue and Wagner, 2000; Weitzman et al., 2000) , both activities have been found for c-Fos in vivo and in vitro in various cell types (Hafezi et al., 1997; Ivanov and Nikolic-Zugic, 1997) . There is evidence that c-Fos and c-Jun represent the main regulators of CD95L expression in response to genotoxic agents Eichhorst et al., 2000) . However, the exact composition of the AP-1 dimer involved in AICD in T cells is presently unknown.
In this study, we have identified an AP-1 site in the 5 To test whether AP-1 is involved in AICD of T cells, we transiently transfected Jurkat T cells with expression vectors encoding dominant negative mutants of Jun, c-FLIP s or empty vector together with a GFP expression plasmid. Apoptosis of GFP-positive cells was determined after 36 h of TCR/CD3 stimulation. Expression of the indicated dominant negative Jun mutants led to a reduction of TCR/CD3-mediated apoptosis ( Figure 1a ). These results demonstrate that c-Jun or one of its dimerization partners are critically involved in TCR/CD3-induced apoptosis.
Recently, we reported that AP-1 is involved in CD95L induction upon drug treatment in human liver cells, resulting in apoptosis (Eichhorst et al., 2000) . Since AICD is blocked in the presence of dominant negative Jun, we tested whether this is due to reduced TCR/CD3-mediated CD95L expression. Jurkat T cells were transiently transfected with a reporter construct containing a 1204 bp fragment 5 0 of the transcription start and 100 bp of the 5 0 UTR (À1204/+100) of the human CD95L gene fused to luciferase. This reporter construct was induced five fold upon TCR/CD3 stimulation. Coexpression of dominant negative Jun mutants reduced CD95L induction compared to transfections with empty vector (Figure 1b ). These results demonstrate that c-Jun or one of its interacting proteins are involved in TCR/CD3-induced CD95L promoter activity.
Drug treatment induces binding of AP-1 (c-Jun/cFos) to a novel AP-1 site in the 5 0 UTR of the CD95L gene, which is necessary for CD95L induction (Eichhorst et al., 2000) . Therefore, we asked whether this site may also be responsible for TCR/CD3-mediated CD95L induction. EMSAs using the sequence containing this AP-1 recognition sequence of the 5 0 UTR (+75+96) resulted in strong induction of a protein/DNA complex within 8 h of TCR/CD3 stimulation in nuclear extracts of Jurkat (Figure 2a 0 UTR in front of firefly luciferase (À1204/+100), previously described (Li-Weber et al., 1998; Eichhorst et al., 2000) , was transiently transfected into Jurkat T cells in the presence of 5 mg of empty vector (c) or expression plasmids encoding the indicated dominant negative versions of Jun. Transfection was performed by using a Bio-Rad Gene Pulser (BioRad Gmbh, Munich, Germany) set at 960 mF, 240 V. To compare transfection efficiency, 3 mg of Renilia luciferase expression vector (Promega, Heidelberg, Germany) was added to the transfection mixture. Transfected cells recovered for 36 h, were stimulated via TCR/CD3 or left untreated for a further 12 h. Then cells were lysed using the lysis buffer contained in the dual luciferase assay system (Promega, Heidelberg, Germany). Luciferase activity was measured as described in the manufacturer's instructions using the DuoLumat LB9507 (Berthold, Wildbach, Germany). Protein determination was performed using the Bio-Rad protein assay (Bio-Rad GmbH, Munich, Germany) to normalize protein content. The results are representative of three independent experiments performed in triplicate Figure 2e . These results demonstrate that TCR/CD3 (re)stimulation induces AP-1 binding, composed of cJun and FosB, to the 5 0 UTR of the CD95L gene. To confirm the absolute requirement of the AP-1 site identified above in TCR/CD3-mediated CD95L gene induction by a functional assay, we compared induction levels of the À1204/+100 and À36/+100 reporter construct containing either wild-type or the mutated AP-1 site in Jurkat T cells. As indicated in Figure 3a , TCR/CD3-mediated induction of the wild-type À1204/ +100 construct (sixfold) was significantly reduced upon mutation of the AP-1 site (2.5-fold). Similarly, the two fold induction of the À36/+100 minimal promoter was completely abolished in its mutant counterpart. However, although FosB is essential for proper induction of the CD95L promoter, FosB alone is not capable of activating the promoter in an overexpression system (Figure 3b ), suggesting that FosB is present in the T cell all the time and c-Jun, as the dimerization partner is the limiting step. These results demonstrate that the AP-1 site in the 5 0 UTR of the human CD95L gene plays an important role in TCR/CD3-mediated induction of CD95L.
In the present study, we demonstrate for the first time that AP-1, composed of FosB and c-Jun, is neccesary for AICD of human T cells. We identified TCR/CD3-induced AP-1 binding to a sequence in the 5 0 UTR of the human CD95L promoter. Mutation of this FosB/c-Jun . EMSAs were performed using nuclear extracts of Jurkat T cells stimulated via TCR/CD3 (CD3) or 6 days activated primary T cells restimulated via TCR/CD3 for the indicated time periods using plate bound anti-CD3 mAbs OKT3 (30 mg/ml) and subsequent crosslinking with 2 mg/ml goat anti-mouse IgG (Pharmingen, Hamburg, Germany). Nuclear extracts were prepared according to the method of Andrews and Faller (1991) . Protein content was determined using the Bio-Rad protein assay. In vitro translated proteins were generated using the TNT Quick Coupled Transcription/Translation Systems (Promega, Heidelberg, Germany). In all, 2.5 pmol doublestranded oliogonucleotides comprising the AP-1 site at +90 in the CD95L promoter were end-labeled with T4 polynucleotide kinase (Roche, Germany) using 25 000 Ci/mmol [g-32 P]ATP (Amersham GmbH, Braunschweig, Germany). Sequences of the single-stranded oligonucleotides were +76/+9S sense (5 0 GAT CGGCTGGCCTGACTCACCAGCA 3 0 ) and +76/+95 antisense (5 0 GATCTGCTGGT-GAGTCAGGCCAGCCG 3 0 ). Binding reactions were carried out at 41C for 30 min using 2.5-5 mg nuclear proteins or 0.5 ml of in vitro translated proteins in a buffer containing 10 mm HEPES, pH 7.5, 0.5 mm EDTA, 100 mm KC1, 2 mm DTT, 2% glycerol, 4% Ficoll 400, 0.25 % NP-40 and 0.1 mg/ml poly dl/dC in a total of 30 ml containing 50 fmol of labeled oligonucleotides. For supershift analysis, 1 mg of antibody was added to the binding reaction. Samples were analysed on a 6% nondenaturing PAGE in 1% Tris-borate-EDTA. (b) As described in (a) using nuclear extracts of TCR/CD3-stimulated Jurkat T cells or restimulated day 6 activated primary T cells (8 h Interestingly, in liver cells chemotherapeutic drugs also lead to activation of AP-1 and binding to the same site in the 5 0 UTR (Eichhorst et al., 2000) . DNAdamaging agents in human T lymphocytes , during thymineless stress in TS(À) human colon carcinoma cells (Harwood et al., 2000) and human liver cell lines, also result in the activation of AP-1 and subsequent CD95L expression. The AP-1-responsive site in T lymphocytes and colon carcinoma cells was identified upstream of the transcription site (Harwood et al., 2000) , whereas in liver cell lines the AP-1 site in Figure 3 Mutated AP-1 strongly reduces TCR/CD3-mediated CD95L induction. (a) Jurkat T cells were transiently transfected with the À1204/+100 or the À36/+100 reporter construct containing either the wild-type (wt) or mutated (mu) AP-1 site in the 5 0 UTR (Eichhorst et al., 2000) and were stimulated via TCR/CD3 for 12 h or left untreated. Luciferase activity was determined 48 h after transfection. The foldinduction levels given with respect to the untreated control culture are indicated. The results are representative of three independent experiments performed in triplicates (b) Jurkat T cells were transiently transfected with the À1204/+100 wild-type reporter construct in the presence of 5 mg or 10 mg of empty vector (c) or an expression plasmid encoding FosB and were stimulated via TCR/CD3 for 12 h or left untreated Function of FosB in T cell apoptosis S Baumann et al the 5
0 UTR was shown to be important (Eichhorst et al., 2000) . In all cases, a heterodimeric complex of c-Jun and c-Fos was suggested to mediate CD95L expression.
Most interestingly, we demonstrate here that upon TCR/CD3 (re)stimulation, AP-1 complexes formed at the CD95L 5 0 UTR are composed of c-Jun and FosB but did not contain significant amounts of c-Fos. AP-1 binding was detectable on the sequence spanning À125 to À95 of the murine CD95L promoter upon TCR/CD3 stimulation, which depends on functional NF-kB binding (Matsui et al., 2000) . The involvement of AP-1 in CD95L expression upon treatment with alkylating agents in fibroblasts derived from c-Jundeficient mouse fetuses has also been described recently (Kolbus et al., 2000) . While c-Fos has been found to exhibit both pro-and antiapoptotic activities, depending on the cell type and stimulus, our data represent the first example of functional data on a critical involvement of FosB in CD95L-initiated apoptosis. Obviously, the type of stimuli dictates the abundance of Fos proteins showing very efficient induction of c-Fos in response to genotoxic agents Eichhorst et al., 2000) , whereas FosB appears to be more efficiently induced upon T-cell activiation.
Most likely, FosB and c-Jun functionally synergize with other transcription factors, such as NF-AT, to facilitate regulated expression of CD95L. Mutation of the NF-AT binding site in the CD95L promoter completely blocks inducible transcription from this promoter (Li-Weber et al., 1998; Rivera et al., 1998) . In cells of the immune system, cooperative NF-AT/AP-1 complexes are induced by stimulation of the antigen receptors of T and B cells (Rao et al., 1997) . Furthermore, AICD is also dependent on the cooperative activity of NF-AT/AP-1 (Macian et al., 2000) . Calcium mobilization activates the phosphatase calcineurin, which dephosphorylates NF-AT and causes its translocation from the cytoplasm to the nucleus (Crabtree, 1999) . Since stimulation of the PKC/Ras pathway results in activation of AP-1 transcription complexes (Karin, 1995) , cooperation between NF-AT and AP-1 proteins thus constitutes a powerful mechanism for signal integration of the calcium and PKC/Ras pathways. Cooperative binding has been demonstrated for the promoter region of several genes (Cockerill et al., 1995; Rooney et al., 1995) . Possibly, NF-AT and AP-1 act together functionally by binding to different DNA sequences in the CD95L promoter. This might explain the weak induction of the À36/+100 reporter construct, which does not include the NF-AT recognition element (Li-Weber et al., 1999) . Regardless of the exact mechanism of cooperativity, our data have extended the number of AP-1 subunits that are involved in apoptosis. Whether or not other apoptotic processes, which are associated with changes in fosB expression, such as glutamate-mediated apoptosis of neuronal cells (Lidwelland Griffiths, 2000) and TGFß-induced apoptosis of hepatocytes and myeloid cells (Yamamura et al., 2000) , are also mediated through FosB/c-Jun-dependent activation remains to be determined.
